Devani AR, Prajapati VH. Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Review. Can Dermatol Today [Internet]. 2021 Mar. 1 [cited 2024 Nov. 21];2(s03):3–8. Available from: https://canadiandermatologytoday.com/article/view/2-s03-devani-prajapati